How many 8-K filings has Sunshine Biopharma Inc. filed?

Sunshine Biopharma Inc. (SBFMW) has 27 8-K (Current Event Report) filings on record, spanning Jan 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Sunshine Biopharma Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Sunshine Biopharma Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Sunshine Biopharma Inc. (SBFMW) — 8-K Filings

All 8-K filings from Sunshine Biopharma Inc.. Browse 27 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (27)

Sunshine Biopharma Files 8-K on Shareholder Vote — Dec 12, 2025 Risk: low
Sunshine Biopharma Inc. filed an 8-K on December 12, 2025, reporting on a matter submitted to a vote of security holders on December 11, 2025. The company, inco
Sunshine Biopharma Files 8-K: Accountant Change & Exhibits — Sep 30, 2025 Risk: low
Sunshine Biopharma Inc. filed an 8-K on September 24, 2025, reporting changes in its certifying accountant and filing financial statements and exhibits. The com
Sunshine Biopharma Files 8-K on Financials — May 19, 2025 Risk: low
Sunshine Biopharma Inc. filed an 8-K on May 19, 2025, reporting events as of May 15, 2025. The filing pertains to Results of Operations and Financial Condition,
Sunshine Biopharma Enters Material Definitive Agreement — Apr 3, 2025 Risk: medium
Sunshine Biopharma Inc. announced on April 2, 2025, that it entered into a material definitive agreement. The company, previously known as Mountain West Busines
Sunshine Biopharma Files 8-K on Financials — Apr 2, 2025 Risk: low
Sunshine Biopharma Inc. filed an 8-K on April 2, 2025, reporting on its Results of Operations and Financial Condition as of April 1, 2025. The filing includes f
Sunshine Biopharma Announces Board & Officer Changes — Jan 15, 2025 Risk: medium
Sunshine Biopharma Inc. announced on January 13, 2025, a significant event related to its board of directors and officer appointments. The filing details the de
Sunshine Biopharma Files 8-K on Shareholder Matters — Dec 10, 2024 Risk: low
Sunshine Biopharma Inc. filed an 8-K on December 10, 2024, reporting on matters submitted to a vote of security holders. The filing details the company's corpor
Sunshine Biopharma Files 8-K on Financials — Nov 7, 2024 Risk: low
Sunshine Biopharma Inc. filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition as of November 6, 2024. The filing incl
Sunshine Biopharma Files 8-K on Governance Changes — Oct 23, 2024 Risk: medium
Sunshine Biopharma Inc. filed an 8-K on October 21, 2024, reporting on the departure of directors, election of new directors, appointment of officers, and compe
Sunshine Biopharma Files 8-K — Sep 10, 2024 Risk: medium
Sunshine Biopharma, Inc. filed an 8-K on September 10, 2024, reporting an "Other Event" that occurred on September 9, 2024. The filing does not contain specific
Sunshine Biopharma Files 8-K on Financials — Aug 19, 2024 Risk: low
Sunshine Biopharma, Inc. filed an 8-K on August 19, 2024, reporting on its results of operations and financial condition. The filing includes financial statemen
Sunshine Biopharma Files 8-K on Corporate Changes — Aug 12, 2024 Risk: low
Sunshine Biopharma, Inc. filed an 8-K on August 12, 2024, reporting an amendment to its articles of incorporation and financial statements. The filing pertains
Sunshine Biopharma Files 8-K on Shareholder Vote Matters — Jul 2, 2024 Risk: low
Sunshine Biopharma, Inc. filed an 8-K on June 28, 2024, reporting on matters submitted to a vote of security holders. The filing indicates a change in the compa
Sunshine Biopharma Files 8-K for Other Events — Jul 1, 2024 Risk: medium
Sunshine Biopharma, Inc. filed an 8-K on June 28, 2024, reporting "Other Events." The filing indicates a change in the company's status or significant corporate
Sunshine Biopharma Files 8-K Report — Jun 11, 2024 Risk: low
On June 11, 2024, Sunshine Biopharma, Inc. filed an 8-K report detailing an "Other Event." The company, previously known as Mountain West Business Solutions, In
Sunshine Biopharma Faces Delisting Concerns — Jun 7, 2024 Risk: high
Sunshine Biopharma, Inc. filed an 8-K on June 7, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company was formerly
Sunshine Biopharma Files 8-K on Financials — May 22, 2024 Risk: low
Sunshine Biopharma, Inc. filed an 8-K on May 22, 2024, reporting on events as of May 21, 2024. The filing pertains to the company's results of operations and fi
Sunshine Biopharma Changes Certifying Accountant — May 8, 2024 Risk: medium
Sunshine Biopharma, Inc. announced on May 7, 2024, a change in its certifying accountant. The company has dismissed its former accountant, and the decision was
Sunshine Biopharma Files 8-K: Accountant Change & Exhibits — May 6, 2024 Risk: medium
Sunshine Biopharma, Inc. filed an 8-K on May 3, 2024, reporting changes in its certifying accountant and filing financial statements and exhibits. The company,
Sunshine Biopharma Files 8-K on Corporate Amendments — Apr 23, 2024 Risk: low
Sunshine Biopharma, Inc. filed an 8-K on April 23, 2024, reporting an amendment to its articles of incorporation and the filing of exhibits. The report details
Sunshine Biopharma Files 8-K on Financials — Apr 1, 2024 Risk: low
On April 1, 2024, Sunshine Biopharma, Inc. filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as well as f
Sunshine Biopharma Files 8-K: Material Agreement, Equity Sales — Mar 6, 2024 Risk: medium
Sunshine Biopharma, Inc. announced on March 4, 2024, that it entered into a material definitive agreement. The company also disclosed unregistered sales of equi
Sunshine Biopharma Faces Delisting Notice — Mar 1, 2024 Risk: high
Sunshine Biopharma, Inc. filed an 8-K on February 28, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company was form
Sunshine Biopharma Files 8-K on Security Holder Vote — Feb 16, 2024 Risk: low
Sunshine Biopharma, Inc. filed an 8-K on February 16, 2024, reporting on matters submitted to a vote of security holders on February 13, 2024. The filing indica
Sunshine Biopharma Enters Material Definitive Agreement — Feb 15, 2024 Risk: medium
Sunshine Biopharma, Inc. filed an 8-K on February 15, 2024, reporting an "Entry into a Material Definitive Agreement" on February 13, 2024. This filing indicate
Sunshine Biopharma Enters Material Definitive Agreement — Feb 12, 2024 Risk: medium
Sunshine Biopharma, Inc. (SBFM) filed an 8-K on February 12, 2024, reporting an "Entry into a Material Definitive Agreement" on February 11, 2024. This filing i
Sunshine Biopharma Reports Officer/Director Changes, Compensation on Jan 25 — Jan 30, 2024
Sunshine Biopharma, Inc. (SBFM) filed an 8-K on January 30, 2024, reporting an event on January 25, 2024, related to the departure or election of directors/offi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX